Brief: Lyra unveils clinical plan for LYR-210, to present late-stage sinusitis trial data
06/10/2025 12:10
Oct 6 (Reuters) - Lyra Therapeutics Inc LYRA.O: LYRA THERAPEUTICS ANNOUNCES CLINICAL PLAN FOR LYR-210 AND LATE-BREAKING ORAL PRESENTATION OF PHASE 3 ENLIGHTEN 2 STUDY LYRA THERAPEUTICS INC - ENLIGHTEN 2 TRIAL MEETS PRIMARY ENDPOINT IN CRS SYMPTOMS Source text: ID:nGNX2tGTg Further company coverage: LYRA.O ((Reuters.Briefs@thomsonreuters.com;))